Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.3.1 has been added to the history. The previous revision entry v3.2.0 has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding-lapse notice was removed from the page; the page now shows the standard government information banner.SummaryDifference0.8%

- Check43 days agoChange DetectedA new version entry (2022-06-16) was added to the Record History, indicating a recruitment status update for NCT04881929, while the page continues to display the study details and prior history entries; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.